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Introduction
Cryopyrin-associated periodic syndromes (CAPS) usually
present in early childhood as an urticaria-like skin rash
associated with an increased inflammatory response,
with additional manifestations (i.e. arthropathy, AA
amyloidosis or deafness) typically restricted to certain
phenotypes. CAPS are caused by dominantly inherited
or de novogain-of-functionNLRP3 mutations. The intro-
duction of next-generation sequencing (NGS) into
clinics has revealed the important role of somatic
NLRP3 mosaicism in these syndromes by means of its
detection in a high proportion of patients who were
apparently mutation-negative by Sanger sequencing.
Thus, NGS technologies are becoming essential for rou-
tinely identifying the genetic cause of the suspected
autoinflammatory disease.
Objective
To describe a Spanish patient with CAPS that start in
adulthood in whom molecular analyses detected a novel
NLRP3 mutation as a somatic mutation.
Patients and methods
Genomic DNA was extracted from peripheral blood.
The analysis of the six most common genes associated
with autoinflammatory diseases (MEFV, TNFRSF1A,
MVK, NLRP3, NOD2 and PSTPIP1) was performed by
NGS. Additional molecular studies of somatic NLRP3
mosaicism were performed by targeted deep sequencing
(TDS).
Results
The patient is a 63 year-old Spanish male who pre-
sented with a generalized urticarial rash, a gradually
worsening oligoarthritis at wrists, elbows and knees, and
a moderate bilateral sensorineural hypoacusia starting in
his 50s. Laboratory results showed a marked leucocyto-
sis, neutrophilia and increased inflammatory markers
without evidence of circulating autoantibodies. Multiple
therapeutic approaches including NSAID, corticoster-
oids, methotrexate and colchicine result in poor or par-
tial responses. Screening of autoinflammatory-associated
genes identified a novel NLRP3 variant (c.1906C>G; p.
Gln636Glu) with an allele frequency of 12.2% (coverage:
738x). We hypothesized that this variant could be a
somatic NLRP3 mutation. TDS confirmed the somatic
NLRP3 mosaicism at 18.4 % (mean of triplicates; mean
coverage: 6225x). Additional analyses showed that this
variant has never been reported in public databases, that
is located on a highly evolutionary conserved amino
acid residue and that is predicted to be possibly dama-
ging by PolyPhen-2 algorithm. Additional functional and
genetic studies are currently ongoing.
Conclusions
We herein describe the case of a patient with a clinical
picture compatible with MWS, with the exception of a
late onset of the disease, who carries a somatic NLRP3
mosaicism. Our findings highlight the diagnostic utility
of NGS technologies in detecting low-level somatic gene
mosaicism and support its use as a routine genetic
screening tool.
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